← Every company

Regeneron Pharmaceuticals Inc SEC Filings

What Regeneron Pharmaceuticals Inc has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.

REGN overview →
Filings on file
142
since Nov 4, 2016
Warning signs
0
none filed
Last results
Oct 6, 2026
8-K item 2.02
Industry
Pharmaceutical Preparations
SIC 2834

Newest first

Each label is a form type or an 8-K item as filed; each row links to the filing.

FiledWhat it reportsDocument
Sep 30, 2026
Executive or director change
8-K
Read ↗
Jan 31, 2024
Executive or director change
8-K
Read ↗
Sep 8, 2023
Executive or director change
8-K
Read ↗
Apr 17, 2023
Executive or director change
8-K
Read ↗
Oct 3, 2022
Executive or director change
8-K
Read ↗
Jan 5, 2021
Executive or director change
8-K
Read ↗
Jun 16, 2020
Executive or director changeShareholder vote
8-K
Read ↗
Jan 18, 2018
Executive or director change
8-K
Read ↗
Jan 2, 2018
Executive or director change
8-K
Read ↗
Jun 14, 2017
Executive or director changeShareholder vote
8-K
Read ↗
Jan 31, 2017
Executive or director change
8-K
Read ↗
Dec 21, 2016
Executive or director change
8-K
Read ↗

Source: Regeneron Pharmaceuticals Inc's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.

More on REGN

Related datasets